2026-09-18T09:54:48-05:00 2025-12-31 873707167 CBIZ ADVISORS LLC 340 MOUNT KEMBLE AVE STE 210N MORRISTOWN NJ 07960 990 2025-01-01 201082179 ALZHEIMER'S DRUG DISCOVERY FOUNDATION ALZH 2129018000 57 WEST 57TH ST 904 NEW YORK NY 10019 ISOBEL COLEMAN CEO 2129018000 2026-09-17 1 AARON FOX P01365820 9739293500 2026-09-17 2025 ISOBEL COLEMAN 57 WEST 57TH ST 904 NEW YORK NY 10019 84182965 0 X WWW.ALZDISCOVERY.ORG X 2004 DE ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT AND TREAT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS. 33 32 37 32 0 0 36045158 66955109 5841351 11651235 5534433 4154966 -137955 -598547 47282987 82162763 73252232 30837976 0 0 8861071 8830102 0 0 4588393 6137124 7929805 88250427 47597883 -40967440 34564880 299394693 315495637 82417926 63362218 216976767 252133419 ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS. 0 0 39974593 30837976 11651235 THE ALZHEIMER'S DRUG DISCOVERY FOUNDATION IS DEDICATED TO RAPIDLY ACCELERATING THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS. THE ADDF IS SOLELY FOCUSED ON FUNDING THE DEVELOPMENT OF DRUGS FOR ALZHEIMER'S, EMPLOYING A VENTURE PHILANTHROPY MODEL TO SUPPORT RESEARCH IN ACADEMIA AND THE BIOTECH INDUSTRY. 39974593 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 49 0 1 37 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 33 32 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 NY AL AR CA CT FL GA HI IL KS KY MA MD MI MN MS NC ND NH NJ NM OR PA RI SC TN UT VA WI WV X MARINA D'EMIC ACTING CFO 2129018000 57 WEST 57TH ST 904 NEW YORK NY 10019 ADAM HOFFMAN GOVERNOR 1.00 X 0 0 0 ALICE SHURE GOVERNOR 1.00 X 0 0 0 ANN JACKSON GOVERNOR 1.00 X 0 0 0 BONNIE ENGLEBARDT LAUTENBERG GOVERNOR 1.00 X 0 0 0 BONNIE PFEIFER EVANS GOVERNOR 1.00 X 0 0 0 CAROL BOULANGER GOVERNOR 1.00 X 0 0 0 DAVID DOLBY GOVERNOR 1.00 X 0 0 0 DAVID R WEINREB GOVERNOR 1.00 X 0 0 0 GARY M LAUDER GOVERNOR 1.00 X 0 0 0 GAVIN COOK GOVERNOR 1.00 X 0 0 0 HENRIK ZETTERBERG MD PHD GOVERNOR 1.00 X 0 0 0 HOWARD FILLIT MD FOUNDING ED & CSO 40.00 X X 691744 0 494274 JULIEANN SHANAHAN CFA GOVERNOR 1.00 X 0 0 0 LANNY EDELSOHN MD GOVERNOR 1.00 X 0 0 0 LAURA STEELE GOVERNOR 1.00 X 0 0 0 LAURENCE LEEDS JR GOVERNOR 1.00 X 0 0 0 LEONARD LAUDER CO-CHAIR/GOVERNOR (DECEASED 06/25) 1.00 X X 0 0 0 MIIA KIVIPELTO MD PHD GOVERNOR 1.00 X 0 0 0 NANCY CORZINE GOVERNOR 1.00 X 0 0 0 NANCY GOODES GOVERNOR 1.00 X 0 0 0 NIRANJAN BOSE PHD GOVERNOR 1.00 X 0 0 0 PAULA ZAHN GOVERNOR 1.00 X 0 0 0 PHILIP SCHELTENS MD PHD GOVERNOR 1.00 X 0 0 0 RACHID IZZAR GOVERNOR 1.00 X 0 0 0 RANDAL SANDLER CO-VICE CHAIR & SECRETARY 1.00 X X 0 0 0 RIC EDELMAN GOVERNOR 1.00 X 0 0 0 RICHARD C MOHS GOVERNOR 1.00 X 0 0 0 ROBERT A BELFER GOVERNOR 1.00 X 0 0 0 ROBERTA DIAZ BRINTON PHD GOVERNOR 1.00 X 0 0 0 RONALD S LAUDER CO-CHAIRMAN /GOVERNOR 1.00 X X 0 0 0 SALLY SUSMAN GOVERNOR 1.00 X 0 0 0 SHARON T SAGER GOVERNOR 1.00 X 0 0 0 THOMAS F MCWILLIAMS CO-VICE CHAIRMAN & TREASURER 1.00 X X 0 0 0 THOMAS S SMITH JR GOVERNOR 1.00 X 0 0 0 KAREN HARRIS CFO & HEAD OF MISSION-REL. INVESTING 40.00 X 384929 0 41275 MARK ROITHMAYR CEO 40.00 X 682100 0 58069 AARON BURSTEIN HEAD OF SEARCH & EVAL. 40.00 X 359652 0 61170 ELI SHOBIN SENIOR DIRECTOR DXA 40.00 X 330179 0 39967 JANE MCINTOSH CHIEF EXT. AFFAIRS & PHILANTHROPY OFFICER 40.00 X 394697 0 27629 PIZZONE KATHRYN D ATTY., MISSION-REL. INVEST. 40.00 X 218807 0 53924 LAURA NISENBAUM EXEC. DIR., DRUG DEV. 40.00 X 496050 0 53715 3558158 0 830023 22 0 1 0 DAVID MONN LLC 150 WEST 28TH STREET SUITE 702 NEW YORK NY 10001 CATERING 750000 VITAL IMPACT LLC 275 7TH AVE 15TH FLOOR NEW YORK NY 10001 CONSULTING SERVICES 723643 BEACON HILL SOLUTIONS GROUP LLC 20 ASHBURTON PL BOSTON MA 02108 STAFFING SERVICES 193585 LAMPROS KOURTIS 188 PROSPECT STREET CAMBRIDGE MA 02139 CONSULTING SERVICES 172813 PBFERRELL LLC 1110 BROOKSIDE DR LEBANON IN 46052 CONSULTING SERVICES 164400 13 2083346 64871763 2919340 66955109 PRI INCOME 900099 11651235 11651235 11651235 4163392 4163392 1001509 1009935 -8426 -8426 -8426 411720 2083346 1010267 -598547 -598547 82162763 11651235 0 3556419 16077916 16077916 14760060 14760060 2352392 1942196 199072 211124 5164582 3099392 716471 1348719 306973 80682 96742 129549 572898 362424 76794 133680 433257 282997 56194 94066 245363 245363 94469 94469 2608757 1153776 1103101 351880 1173141 525778 302025 345338 97396 37926 37763 21707 244332 95143 94734 54455 350123 201916 61864 86343 607651 481408 24698 101545 495467 392531 20139 82797 43306 43306 VENUE, CATERING AND OTH 1587100 108803 8955 1469342 MISCELLANEOUS 225066 87641 87264 50161 PUBLIC RELATIONS 157634 38641 11306 107687 47597883 39974593 3034897 4588393 7163054 1935740 47754709 55513070 170715532 167077902 706750 282684 765496 652843 134734 112653 70622086 88836708 2297828 1736880 299394693 315495637 3274049 3388117 75579333 56727600 1437114 1506635 2127430 1739866 82417926 63362218 X 64971491 92558628 152005276 159574791 216976767 252133419 299394693 315495637 34564880 591772 0 X X 0 1 X 1 0 X 41612740 249842003 30595495 36045158 66955109 425050505 41612740 249842003 30595495 36045158 66955109 425050505 234170430 190880075 206491 857675 3119289 4100926 4163392 12447773 437498278 37264772 0.43630 0.35600 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 178540 178540 0 586956 474303 112653 112653 OPERATING LEASE LIABILITY 1739866 1739866 X 82294576 591772 -365490 226282 82068294 94469 94469 82162763 47137924 0 47137924 94469 365490 459959 47597883 PART X, LINE 2: THE FOUNDATION BELIEVES IT HAS NO UNCERTAIN TAX POSITIONS AS OF DECEMBER 31, 2025 AND 2024, IN ACCORDANCE WITH ASC TOPIC 740, INCOME TAXES, WHICH PROVIDES STANDARDS FOR ESTABLISHING AND CLASSIFYING ANY TAX PROVISIONS FOR UNCERTAIN TAX POSITIONS. PART XI, LINE 2D - OTHER ADJUSTMENTS: INDIRECT FUNDRAISING EXPENSES -365,490. PART XII, LINE 4B - OTHER ADJUSTMENTS: INDIRECT FUNDRAISING EXPENSE 365,490. 1 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH 13231452 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH 1036093 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH 492515 0 0 0 0 0 0 14760060 0 14760060 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, RESEARCH 68055 ELECTRONIC 0 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, RESEARCH 424460 ELECTRONIC 0 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES RESEARCH 1036093 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 121000 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 150000 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 15000 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 972668 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 2231371 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 213348 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 873830 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 3809420 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 42500 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 1999997 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 150000 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 2549203 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 78115 ELECTRONIC 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM RESEARCH 25000 ELECTRONIC 0 17 0 0 0 0 0 0 PART I, LINE 2: GRANT RECIPIENTS ARE REQUIRED TO SEND PROGRESS REPORTS AS OUTLINED IN THEIR EXECUTED CONTRACTS. PALM BEACH 731850 683250 48600 339757 103096 115835 MEMORIES MATTER 675047 543967 131080 74020 89455 7556 6 1088169 856129 232040 92830 179454 8264 2495066 2083346 411720 506607 372005 131655 1010267 -598547 1 ALZHEIMERS DISEASE DATA INITIATIVE (ADDI) 4110 CARILLON POINT KIRKLAND WA 98033 853776266 501(C)(3) 1881800 0 ALZHEIMERS RESEARCH BANNER HEALTH 2901 N CENTRAL AVE SUITE 160 PHOENIX AZ 85012 450233470 501(C)(3) 250000 0 ALZHEIMERS RESEARCH BETH ISRAEL DEACONESS MEDICAL CENTER 330 BROOKLINE AVENUE BOSTON MA 02215 042103881 501(C)(3) 349590 0 ALZHEIMERS RESEARCH CIRCULAR GENOMICS INC 5901 INDIAN SCHOOL RD NE ALBUQUERQUE NM 87110 861873272 501(C)(3) 250000 0 ALZHEIMERS RESEARCH CLEARVIEW HEALTHCARE PARTNERS 275 WASHINGTON STREET NEWTON MA 02458 261597664 501(C)(3) 462500 0 ALZHEIMERS RESEARCH EMORY UNIVERSITY 1521 CLIFTON RD ATLANTA GA 30322 580566256 501(C)(3) 353147 0 ALZHEIMERS RESEARCH EMTHERAPRO 200 E PONCE DE LEON AVENUE SUITE 225 DECATUR GA 30030 384182092 499415 0 ALZHEIMERS RESEARCH ICAHN SCHOOL OF MEDICINE 1 GUSTAVE LEVY PLACE NEW YORK NY 10029 136171197 501(C)(3) 598982 0 ALZHEIMERS RESEARCH INDIANA UNIVERSITY 509 E 3RD ST BLOOMINGTON IN 47401 356001673 501(C)(3) 502277 0 ALZHEIMERS RESEARCH JOHNS HOPKINS UNIVERSITY 3400 NORTH CHARLES STREET BALTIMORE MD 21205 520595110 501(C)(3) 640000 0 ALZHEIMERS RESEARCH MILKEN INSTITUTE 1250 4TH ST 2ND FLOOR SANTA MONICA CA 90401 954240775 501(C)(3) 75000 0 ALZHEIMERS RESEARCH STANFORD UNIVERSITY 1201 WELCH RD MSLS BLDG ROOM P252 STANFORD CA 94035 941156365 501(C)(3) 350385 0 ALZHEIMERS RESEARCH STANFORD UNIVERSITY 1201 WELCH RD MSLS BLDG ROOM P252 STANFORD CA 94035 941156365 501(C)(3) 128500 0 ALZHEIMERS RESEARCH SUNBIRD BIO INC 35 CAMBRIDGEPARK CAMBRIDGE MA 02140 474956987 501(C)(3) 249887 0 ALZHEIMERS RESEARCH SUPERFLUID DX 259 EAST GRAND AVE SUITE 325 SAN FRANCISCO CA 94080 474885455 501(C)(3) 911250 0 ALZHEIMERS RESEARCH THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS 5323 HARRY HINES BLVD DALLAS TX 75390 756002868 501(C)(3) 600000 0 ALZHEIMERS RESEARCH TRANSPOSON THERAPEUTICS 4660 LA JOLLA VILLAGE DRIVE SUITES 100 200 SAN DIEGO CA 92122 4995519 0 ALZHEIMERS RESEARCH TRUSTEES OF BOSTON UNIVERSITY COMMONWEALTH AVE BOSTON MA 02215 042103547 501(C)(3) 64000 0 ALZHEIMERS RESEARCH UNIVERSITY OF ILLINOIS AT CHICAGO 1200 WEST HARRISON STREET CHICAGO IL 60607 376000511 501(C)(3) 599515 0 ALZHEIMERS RESEARCH UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET PHILADELPHIA PA 19104 231352685 501(C)(3) 350000 0 ALZHEIMERS RESEARCH UNIVERSITY OF SOUTH FLORIDA 3802 SPECTRUM BLVD STE 100 TAMPA FL 33612 592959590 501(C)(3) 263649 0 ALZHEIMERS RESEARCH USAGAINSTALZHEIMER'S 5614 CONNECTICUT AVE NW 288 WASHINGTON DC 20015 450672514 501(C)(3) 15000 0 ALZHEIMERS RESEARCH WASHINGTON UNIVERSITY IN ST LOUIS ONE BROOKINGS DRIVE ST LOUIS MO 63130 430653611 501(C)(3) 1687500 0 ALZHEIMERS RESEARCH 21 2 PART I, LINE 2: GRANT RECIPIENTS ARE SELECTED THROUGH A RIGOROUS PEER-REVIEW PROCESS, AS WELL AS, AN INTERNAL REVIEW AND BOARD APPROVAL PROCESS. GRANTS FOR ALL INSTITUTIONS ARE CLOSELY MONITORED. GRANTEES MUST SUBMIT MID-YEAR AND END-OF-YEAR PROGRESS AND FINANCIAL REPORTS. SUBSEQUENT PAYMENTS TO GRANT RECIPIENTS ARE CONTINGENT UPON THE RECEIPT AND SATISFACTORY REVIEW OF THESE REPORTS. PROGRESS OF GRANT RECIPIENTS IS COMMUNICATED TO THE BOARD OF GOVERNORS PERIODICALLY. GRANT RECIPIENTS ARE REQUIRED TO SEND PROGRESS REPORTS AS OUTLINED IN THEIR EXECUTED CONTRACTS. SOME OF THE GRANTS LISTED IN PART II OF THIS SCHEDULE I ARE GRANTS WITH A "PARTICIPATING INTEREST," WHICH ENTITLE THE FOUNDATION TO RECEIVE, IN THE EVENT THAT THE FUNDED PROJECT IS LICENSED OR OTHERWISE COMMERCIALIZED, A PERCENTAGE OF THE LICENSING OR OTHER REVENUE THAT THE GRANTEE ORGANIZATION RECEIVES OR EQUITY IN THE RESULTING BUSINESS ENTITY. X X X X 1 1 0 0 0 0 0 1 0 HOWARD FILLIT MD FOUNDING ED & CSO 675256 0 0 0 16488 0 463688 0 30586 0 1186018 0 0 0 MARK ROITHMAYR CEO 676004 0 0 0 6096 0 27800 0 30269 0 740169 0 0 0 LAURA NISENBAUM EXEC. DIR., DRUG DEV. 457882 0 35000 0 3168 0 27800 0 25915 0 549765 0 0 0 KAREN HARRIS CFO & HEAD OF MISSION-REL. INVESTING 381761 0 0 0 3168 0 27800 0 13475 0 426204 0 0 0 JANE MCINTOSH CHIEF EXT. AFFAIRS & PHILANTHROPY OF 393593 0 0 0 1104 0 27629 0 0 0 422326 0 0 0 AARON BURSTEIN HEAD OF SEARCH & EVAL. 327588 0 30000 0 2064 0 26915 0 34255 0 420822 0 0 0 ELI SHOBIN SENIOR DIRECTOR DXA 227928 0 0 0 102251 0 19763 0 20204 0 370146 0 0 0 PIZZONE KATHRYN D ATTY., MISSION-REL. INVEST. 218375 0 0 0 432 0 17154 0 36770 0 272731 0 0 0 PART I, LINES 4A-B DURING 2025, ELI SHOBIN RECEIVED $79,248 IN SEVERANCE PAY AND IT IS INCLUDED IN COLUMN B(III). HOWARD FILLIT RECEIVED A CONTRIBUTION TO A 457(F) PLAN FOR $443,178 AND IT IS INCLUDED IN COLUMN (C). PART I, LINE 7 THE COMPENSATION COMMITTEE APPROVED THE BONUSES REPORTED IN COLUMN B(II) FOR LAURA NISENDBAUM AND AARON BURNSTEIN. X 8 2919340 FMV 0 1 0 PART I, COLUMN (B): COLUMN (B) REFLECTS THE TOTAL NUMBER OF CONTRIBUTORS. PART I, LINE 32B: IT IS ADDF'S POLICY TO MAINTAIN APPROPRIATE BUSINESS RELATIONSHIPS WITH REGARD TO GIVING AND RECEIVING CORPORATE GIFTS. EMPLOYEES SHOULD USE GOOD JUDGMENT WHEN ENTERTAINING CUSTOMERS AND BUSINESS PARTNERS AND SUCH ENTERTAINMENT SHOULD NOT EXCEED TYPICAL MEAL AND ASSOCIATED EXPENSES. EMPLOYEE SHOULD DISCOURAGE OTHERS FROM OFFERING EXTRAVAGANT MEALS OR ENTERTAINMENT. SPECIAL CARE MUST BE TAKEN TO AVOID EVEN THE IMPRESSION OF A CONFLICT OF INTEREST. IF AN EMPLOYEE IS IN DOUBT ABOUT THE APPROPRIATENESS OF A PLANNED EVENT OR GIFT TO BE GIVEN ON BEHALF OF ADDF, CONTACT THE CHIEF OF STAFF OR THE CEO FORM 990, PART VI, SECTION A, LINE 1A THE FOUNDATION HAS A TWO CLASS BOARD STRUCTURE (CLASS A AND CLASS B) PURSUANT TO WHICH EACH CLASS A BOARD MEMBER IS ENTITLED TO ONE VOTE AND EACH CLASS B MEMBER IS ENTITLED TO ONE-HALF VOTE. FORM 990, PART VI, SECTION A, LINE 2 THE FOLLOWING FAMILY AND/OR BUSINESS RELATIONSHIPS EXIST AMONG GOVERNORS AND OFFICERS OF THE FOUNDATION: (I) LEONARD A. LAUDER AND RONALD S. LAUDER: FAMILY AND BUSINESS RELATIONSHIP; (II) LEONARD A. LAUDER, AND GARY M. LAUDER: BUSINESS AND FAMILY RELATIONSHIP; (III) LEONARD A.LAUDER, RONALD S. LAUDER AND DR. HOWARD FILLIT: BUSINESS RELATIONSHIP; (IV) ALICE SHURE AND BONNIE PFEIFER EVANS: FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B A DRAFT OF THE COMPLETED FORM 990 IS REVIEWED BY THE FOUNDATION'S CHIEF FINANCIAL OFFICER AND FINANCE DIRECTOR. THEN A COPY IS PROVIDED TO THE BOARD OF GOVERNORS AND THE FOUNDATION'S OFFICERS. THE FINAL FORM 990 IS SIGNED BY EITHER THE FOUNDATION'S FOUNDING EXECUTIVE DIRECTOR, TREASURER OR THE CFO. FORM 990, PART VI, SECTION B, LINE 12C AT LEAST ANNUALLY, CONFLICT OF INTEREST DISCLOSURE STATEMENTS ARE CIRCULATED TO THE BOARD OF GOVERNORS AND OFFICERS FOR REVIEW AND COMPLETION. THE COMPLETED STATEMENTS ARE THEN REVIEWED UNDER THE SUPERVISION OF A FOUNDATION OFFICER. FORM 990, PART VI, SECTION B, LINE 15A IN 2021, THE ADDF ENGAGED A BENCHMARKING/SALARY ASSESSMENT CONSULTANT WHO ANALYZED ALL ROLES. THEY PROVIDED A FULL REPORT MARKET ANALYSIS ON THE CEO AND FOUNDING ED'S COMPENSATION, AND THE PRESENTATION WAS REVIEWED/SHARED WITH RANDAL SANDLER, CO-VICE CHAIR OF THE ADDF BOARD. ADDITIONALLY, THEIR PERFORMANCE AND SALARY IS REVIEWED ANNUALLY, ALONG WITH OTHER ADDF STAFF, BY RANDAL SANDLER. STARTING IN 2023, THEY HAVE ESTABLISHED THE COMPENSATION COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST. FORM 990, PART XII, LINE 2C: THE PROCESS HAD NOT CHANGED FROM PRIOR YEAR.